|
Abstract Objective: To study the therapeutic effect of Baofukang suppository combined with progestil capsule for treating postmenopausal women with human papillomavirus (HPV) infection. Methods: From January 2016 to January 2018, 98 postmenopausal women with HPV infection were selected and were randomly divided into the study group and control group (49 cases in each group）. The women in the study groups were treated by Baofukang suppository combined with progestil capsule, and the women in the control group were treated by Baofukang suppository. The clinical efficacy and levels of inflammatory factors of women in both groups were evaluated. Results: 3 months after treatment, rate of negative HPV, clinical efficacy and inflammatory factors of all women had improved, and the rate of negative HPV and total clinical efficacy rate of women in the study group were 91.8% and 89.8%, which were significant higher than those (65.3% and 67.3%) of women in the control group (P＜0.05), and the levels of inflammatory factors of women in the study group were significant lower than those of women in the control group (P＜0.05). Conclusion: Baofukang suppository combined with prostaglandin capsule for treating postmenopausal women with HPV can help clearance of HPV, can alleviate the clinical symptoms, and can increase clinical effectiveness.
|
|
|
|
|
|
